Rds
10
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)
Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Neonates
Dexmedetomidine for LISA Procedure in Preterm Infants
Fetal Pulmonary Artery Acceleration to Ejection Time Ratio (PATET) in the Prediction of Subsequent Development of Respiratory Distress Syndrome (RDS)
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
High Flow Ventilation With Volume Guarantee
A Multi-Site Study of Music Therapy Interventions on Vitals, Feeding and Sleep in Premature Infants
Determination of Lung Maturity and Prediction of RDS at Birth
Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants
Intratracheal Vitamin A Administration With Surfactant for Newborn Respiratory Distress Syndrome